2023/09/29 09:26:05 | |
---|---|
Price | |
105.05 EUR | |
Difference | 0.43% (0.45) |
ISIN | BE0003470755 |
Symbol | SOLB |
Exchange | Euronext Brussels |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,854 EUR |
Benchmark | BEL 20 INDEX |
Bid (Bid size) | 105.00 EUR (66) |
Ask (Ask size) | 105.05 EUR (60) |
Open | 105.45 EUR |
High | 105.45 EUR |
Low | 104.75 EUR |
Close (prev. day) | 104.60 EUR |
VWAP | 105.23238 EUR |
Volume (pcs) | 3,164 |
Trading volume | 332,955.00 |
Number of trades | 115 |
Last size | 63 |
Related Futures | 23 |
Related Options | - |
Date | Headline | Download | |
2023/09/08 |
![]() |
Global Equity Ratings |
![]() |
2023/08/22 |
![]() |
Global Equity Ratings |
![]() |
2023/08/17 |
![]() |
Global Equity Ratings |
![]() |
2023/08/09 |
![]() |
Global Equity Ratings |
![]() |
2023/07/21 |
![]() |
Global Equity Ratings |
![]() |
2023/09/29 09:26:05 | |
---|---|
Price | |
105.05 EUR | |
Difference | 0.43% (0.45) |
ISIN | BE0003470755 |
Symbol | SOLB |
Exchange | Euronext Brussels |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,854 EUR |
Benchmark | BEL 20 INDEX |
Bid (Bid size) | 105.00 EUR (66) |
Ask (Ask size) | 105.05 EUR (60) |
Open | 105.45 EUR |
High | 105.45 EUR |
Low | 104.75 EUR |
Close (prev. day) | 104.60 EUR |
VWAP | 105.23238 EUR |
Volume (pcs) | 3,164 |
Trading volume | 332,955.00 |
Number of trades | 115 |
Last size | 63 |
6m | 1Y | 3Y | |
Perf (%) | +1.65% | +30.13% | +39.47% |
Perf (abs.) | +1.70 | +24.22 | +29.60 |
Beta | 1.10 | 1.18 | 1.19 |
Volatility | 24.98 | 26.37 | 28.46 |
Ø price 5 days | Ø volume 5 days (pcs.) | 104.31 EUR (146,625) |
Ø price 30 days | Ø volume 30 days (pcs.) | 105.96 EUR (153,037) |
Ø price 100 days | Ø volume 100 days (pcs.) | 104.21 EUR (173,898) |
Ø price 250 days | Ø volume 250 days (pcs.) | 102.20 EUR (198,757) |
YTD High | date | 112.95 EUR (2023/02/21) |
YTD Low | date | 94.12 EUR (2023/03/20) |
52 Weeks High | date | 112.95 EUR (2023/02/21) |
52 Weeks Low | date | 77.46 EUR (2022/09/29) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2023/09/28 | 09:05 | 103.50 EUR | 0.00 | 3 |
Tradegate | 2023/09/29 | 09:25 | 105.20 EUR | 0.00 | 3 |
Stuttgart | 2023/09/29 | 09:03 | 104.85 EUR | 0.00 | 1 |
Munich | 2023/09/29 | 08:05 | 104.40 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2023/09/29 | 08:59 | 105.525 EUR | 0.00 | 1 |
Frankfurt | 2023/09/29 | 09:07 | 105.05 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2023/09/01 | 15:30 | 117.11 USD | 0.02 | 2 |
Euronext Brussels | 2023/09/29 | 09:26 | 105.05 EUR | 0.33 | 115 |
Duesseldorf | 2023/09/29 | 08:10 | 104.05 EUR | 0.00 | 1 |
Berlin | 2023/09/29 | 08:05 | 104.30 EUR | 0.00 | 1 |
BX Swiss | 2023/03/03 | 18:00 | 108.056 CHF | 0.00 | 1 |
SOLVAY SA |
- - |
310, rue de Ransbeek - 1120 Brüssel |
Telefon: +32-2-264-21-11 |
Fax: +32-2-264-30-61 |
E-mail: - |
Solvay SA engages in the manufacture and distribution of chemical and plastic products. It operates through the following segments: Advanced Formulations, Advanced Materials, Performance Chemicals and Corporate and Business Services. The Advanced Formulations segment offers specialty formulations that impact surface chemistry and alter liquid behavior. The Advanced Materials segment materials for multiple applications primarily in the automotive, aerospace, electronics and health markets. The Performance Chemicals segment operates in mature and resilient markets and has positions in chemical intermediates. The Corporate and Business Services segment includes corporate and other business services, such as the research & innovation center. The company was founded by Ernest Solvay in 1863 and is headquartered in Brussels, Belgium. |
Ilham Kadri | Chairman of Managing Board |
Augusto Di Donfrancesco | Member of Executive Committee |
Dominique Golsong | Member of Executive Committee |
Hervé Tiberghien | Member of Executive Committee |
Karim Hajjar | Member of Executive Committee |
Marc Chollet | Member of Executive Committee |
Nicolas Jacques Boël | Chairman of Supervisory Board |
Françoise de Viron | Member of Supervisory Board |
Gilles Michel | Member of Supervisory Board |
Wolfgang Colberg | Member of Supervisory Board |
Agnès Lemarchand | Member of Supervisory Board |
Aude Thibaut de Maisières | Member of Supervisory Board |
Edouard Janssen | Member of Supervisory Board |
Hervé François André Coppens d'Eeckenbrugge | Member of Supervisory Board |
Marjan Johanna Oudeman | Member of Supervisory Board |
Matti Juhani Lievonen | Member of Supervisory Board |
Pierre Gurdjian | Member of Supervisory Board |
Rosemary Thorne | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer